Evaluation of hemostasis in patients with end-stage renal disease
Open Access
- 20 February 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (2) , e0212237
Abstract
An increased bleeding risk is reported for patients with end-stage renal disease. This study aims to analyze, whether bleeding risk can be assessed by global tests of hemostasis. Standard laboratory tests and an extended evaluation of hemostasis by rotational thromboelastometry, platelet function analyzer (PFA) and multiple electrode aggregometry as well as thrombin generation assays and measurement of fibrinolytic potential were performed in 20 patients on hemodialysis, 10 patients on peritoneal dialysis, 10 patients with chronic kidney disease stage G5 (CKD5) and in 10 healthy controls (HC). Hemoglobin was significantly lower in patients with end-stage renal disease versus HC (each p<0.01). Patients on peritoneal dialysis showed increased fibrinogen levels compared to HC (p<0.01), which were also reflected by FIBTEM results (each p<0.05). 41% of hemodialysis patients and 44% of CKD5 patients presented with prolonged PFA-ADP-test (p<0.05), while no patient on peritoneal dialysis and no HC offered this modification. Thrombin generating potential was significantly lower in patients on hemodialysis, while clot lysis time revealed a hypofibrinolytic state in patients on hemo- and peritoneal dialysis compared to HC (p<0.001). In conclusion, patients with end-stage renal disease have complex hemostatic changes with both hyper- and hypocoagulable features, which are dependent on use and type of dialysis. Hypercoagulable features include elevated fibrinogen levels and a hypofibrinolytic state, whereas hypocoagulable features include decreased thrombin generating capacity and platelet dysfunction. Our results may contribute to a more rational approach to hemostatic management in these patients.Keywords
This publication has 29 references indexed in Scilit:
- Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patientsJournal of Thrombosis and Haemostasis, 2012
- Red Blood Cell Transfusion Risks in Patients with End‐Stage Renal DiseaseSeminars in Dialysis, 2012
- Multiplate®Whole Blood Impedance Point of Care Aggregometry: Preliminary Reference Values in Healthy Infants, Children and AdolescentsKlinische Padiatrie, 2010
- Whole Blood Multiple Electrode Aggregometry Is a Reliable Point-of-Care Test of Aspirin-Induced Platelet DysfunctionAnesthesia & Analgesia, 2009
- Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombastheniaPlatelets, 2009
- Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatmentThrombosis and Haemostasis, 2008
- Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal InsufficiencyCirculation, 2003
- Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Bleeding in Renal Failure: Altered Platelet Function in Chronic Uraemia only Partially Corrected by HaemodialysisNephron, 1978
- Adenosine Diphosphate in Red Cells as a Factor in the Adhesiveness of Human Blood PlateletsNature, 1961